Sucralose sabotages cancer treatment
What if a harmless sweetener prevents the success of cancer treatment? A new study shows that sucralose, the ubiquitous artificial sugar substitute, can affect the immune system to such an extent that modern immunotherapies lose their effectiveness.
Researchers from the UPMC Hillman Cancer Center and the University of Pittsburgh report a previously unknown effect of sucralose in Cancer Discovery: In mouse models and in patients with melanoma and non-small cell lung cancer, increased consumption of the sweetener led to significantly reduced efficacy of modern cancer immunotherapies.
How does immunotherapy work?
These therapies work by releasing certain “brakes” on the immune system, known as immune checkpoints. Normally, these checkpoints prevent immune cells from attacking the body’s own cells. Many tumors use this mechanism to camouflage themselves and evade the immune response. Checkpoint inhibitors remove this camouflage and activate T cells, which then destroy cancer cells in a targeted manner.
How does sucralose interfere with immunotherapy?
But sucralose throws this finely tuned system out of balance. The sweetener alters the intestinal microbiome, reduces the diversity of beneficial bacteria and weakens T-cell activity. The result: a dampened immune response and less successful treatment. In the experiments, even the quantities achieved through the consumption of light drinks showed clear effects.
Although the authors emphasize that further studies are still needed, the data illustrate how strongly diet, microbiome and immune defense are linked.
What tastes sweet can end bitterly in cancer treatment.
What is important to you – in a nutshell!
- Sucralose alters the intestinal microbiome and dampens the immune system.
- Immunotherapies lose their effectiveness as a result
- Even realistic consumption levels show effects.
- Nutrition and the microbiome directly influence the success of therapy.
Read more on Bacteria.de: Sucralose – the sweet poison
Source:
Cancer Discovery (2025) – Sucralose consumption ablates cancer immunotherapy efficacy, DOI: 10.1158/2159-8290.CD-25-0247
